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ABSTRACT
Gfi-1B (growth factor independence-1B) gene is an
erythroid-specifictranscriptionfactor,whoseexpres-
sion plays an essential role in erythropoiesis. Our
laboratory has previously defined the human Gfi-1B
promoter region and shown that GATA-1 mediates
erythroid-specific Gfi-1B transcription. By further
investigating the regulation of the Gfi-1B promoter,
here we report that (i) Gfi-1B transcription is negat-
ively regulated by its own gene product, (ii) GATA-1,
instead of Gfi-1B, binds directly to the Gfi-1-like sites
in the Gfi-1B promoter and (iii) Gfi-1B suppresses
GATA-1-mediated stimulation of Gfi-1B promoter
through their protein interaction. These results not
only demonstrate that interaction of GATA-1 and
Gfi-1B participates in a feedback regulatory pathway
in controlling the expression of the Gfi-1B gene, but
alsoprovidethefirstevidencethatGfi-1Bcanexertits
repression function by acting on GATA-1-mediated
transcription without direct binding to the Gfi-1 site
of the target genes. Based on these data, we propose
that this negative auto-regulatory feedback loop is
important in restricting the expression level of
Gfi-1B, thus optimizing its function in erythroid cells.
INTRODUCTION
Gﬁ-1B (growth factor independence-1B) is an erythroid-
speciﬁc Gﬁ-family transcriptional factor, which was identiﬁed
by low stringency hybridization screening with a partial Gﬁ-1
cDNA probe (1). Both Gﬁ-1 and Gﬁ-1B contain a SNAG
domain that mediates transcriptional repression and a zinc
ﬁnger domain at its C-terminus for their DNA binding to
the TAAATCAC(A/T)GCA recognition sequence (1–3).
Expression of Gﬁ-1B is conﬁned in erythroid lineage cells
and megakaryocytes in human (4,5), whereas Gﬁ-1 is more
abundant in the lymphopoietic thymus (6–8). So far, p21
(cip1/waf1), Socs1 and Socs3 are known as the target genes
of Gﬁ-1B-mediated transcriptional repression (1,9). Since
p21 is a cell cycle inhibitor and SOCS family members are
known to suppress cytokine signaling, the functional role of
Gﬁ-1B is considered to be important in controlling prolifera-
tion of erythrocyte/megakaryocyte-lineage cells. Its import-
ance in erythropoiesis has been further highlighted by gene
targeting experiment showing that Gﬁ-1B gene disruption
results in embryonic lethality due to loss of red blood cell
formation (10).
Enforced expression experiment in early erythroid progen-
itor cells has shown that Gﬁ-1B induces a drastic expansion of
erythroblast independent of its SNAG repression domain with
a parallel increase of GATA-2 expression, which is required
for proliferation of erythroblasts (5). On the other hand, a
recent study has shown that Gﬁ-1B plays a critical role in
terminal differentiation through its transcription repression
function (11). Likely, the function of Gﬁ-1B in erythropoiesis
is highly dependent on cell stage and the sequence context of
its targeted gene promoter. Despite the differential roles of
Gﬁ-1B in different stages of differentiation, results of both
studies indicate that elevation of Gﬁ-1B level alters the pro-
gram of normal erythropoiesis (5,11). However, it remains
unclear how Gﬁ-1B expression is regulated in erythroid
cells and whether there is a direct relationship between
Gﬁ-1B and other transcription factor that is involved in
erythropoiesis.
The expression of many eukaryotic transcription factors has
been shown to be auto-regulated positively and negatively
(12–16). In most auto-regulatory cases, a given factor binds
to its own promoter and either activates or represses transcrip-
tion. In this study, we observed negative auto-regulation of
Gﬁ-1B in K562 cells. By analyzing the sequence of human
Gﬁ-1B gene promoter region (17), we found the presence of
two tandem repeats of Gﬁ-1-like sites located at  59/ 56 and
 47/ 44 relative to its transcription start site. Very recently, a
report has demonstrated that mouse Gﬁ-1B directly binds to
the Gﬁ-1 binding sites near the mRNA transcription start site
of the mouse Gﬁ-1B promoter and is able to auto-repress its
own expression (18). However, here we showed that mutations
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doi:10.1093/nar/gki838in these two Gﬁ-1-like sites reduced the promoter activity of
the human Gﬁ-1B promoter in K562 cells, indicating that these
sites mediate transcriptional activation rather than silencing.
By detailed DNA-binding analyses, we proved that GATA-1,
instead of Gﬁ-1B, is the main transcription factor preferen-
tially binding to these non-typical GATA sites. Furthermore,
we found that the Gﬁ-1B can form a complex with GATA-1,
by which GATA-1-mediated transcription is repressed by
Gﬁ-1B. Coincidentally, one recent report also showed that
Gﬁ-1B forms a complex with GATA-1 and associates with
the myc and myb promoters in mouse erythroleukemic (MEL)
cells. Given the facts that overexpression of Gﬁ-1B in ery-
throid progenitors induces growth arrest and that expression of
myc and myb is often associated with cell proliferation, they
hypothesized that GATA-1/Gﬁ-1B is a repressive complex
that suppresses transcription of myc and myb genes (19).
Our results, on the other hand, present the ﬁrst direct evidence
that transcriptional repression function of Gﬁ-1B can work
through its interaction with GATA-1 independent of its direct
DNA binding to the gene promoter. Since our previous study
has shown that GATA-1 is a necessary transcription factor for
Gﬁ-1Bexpression, theauto-regulatorymechanism observedin
this study reﬂects that the expression of Gﬁ-1B and the func-
tion of GATA-1 are mutually regulated in K562 cells.
MATERIALS AND METHODS
Cell culture
K562 cells were maintained in RPMI 1640 (Invitrogen Life
Technologies) supplemented with 10% heat-inactivated fetal
bovine serum (FBS) (HyClone), 2 mM L-glutamine, 100 U of
penicillin G per ml and 100 U of streptomycin per ml. 293T
cells were grown in DMEM containing 10% FBS.
Preparation of nuclear extracts and gel-shift analysis
Nuclear extracts prepared from K562 and 293T cells and gel-
shift reaction were as described previously (20). Competitive
DNA oligomer, GATA-1 (C-20, Santa Cruz, CA), Gﬁ-1B
(H-150, Santa Cruz) or FLAG (M2, Sigma) antibody was
added to the nuclear extracts for 30 min on ice prior to the
DNA-binding reaction. After DNA-binding reaction at
room temperature for 25 min, samples were analyzed by
electrophoresis at 150 V for 2.5 h through the nondenatur-
ing 4% polyacrylamide gels. Gels were then dried for auto-
radiography.
Plasmid constructs and site-directed mutagenesis
Two AATC sites at  59/ 56 and  47/ 44 within the pro-
moter region were simultaneously mutated to GGTC in the
pGL2-hG ( 325/+19) using Quick-Change Site-directed
Mutagenesis Kit (Stratagene). A 3XGATA-T81-Luc reporter
plasmid was constructed by inserting oligonucleotide con-
taining three tandem copies of GATA-1 binding site
(50-GATCAGAAGCTT CACTTGATAACAGAAAGTGATA-
ACAGAAAGTGATAATCTGTCGACCGTCGT-30) upstream
of a minimal herpes simplex thymidine kinase promoter in
the pT81 luciferase vector (21), which was provided by
A. Iwama (5) (Laboratory of Stem Cell Therapy, Center for
Experimental Medicine, The Institute of Medical Science,
University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo,
108-8639, Japan). Expression vector of Gﬁ-1B-FLAG, in
which FLAG is tagged at the C-terminus of Gﬁ-1B, was con-
structed by ligating the PCR DNA fragment spanning the open
reading frame region with the EcoRI/SalI digested pRK5-
FLAG plasmid. To generate the expression vectors of the
wild-type and deleted mutants of Myc-GATA-1, the regions
covering 1–414, 1–199, 1–255 or 1–287 amino acids of
mGATA-1 cDNA were ampliﬁed by PCR and inserted to
the XhoI site of plasmid pCS2-MT (provided by Dave Turner,
University of Michigan).The wild-type and deleted mutantsof
FLAG-Gﬁ-1B covering 1–330, 164–330 and 1–137 amino
acids of hGﬁ-1B cDNA were each subcloned into the KpnI
andXbaIsitesofplasmidpCMV2togeneratethepCMV2-Gﬁ-
1B (wild type), pCMV2-Gﬁ-1B (N-del) and pCMV2-Gﬁ-1B
(C-del) constructs. Another deleted mutant construct covering
45–330 amino acids of hGﬁ-1B cDNA was subcloned into the
HindIII and EcoRI sites of plasmid pCMV2 to generate the
pCMV2-Gﬁ-1B (DSNAG) constructs. The VP16-Gﬁ-1B con-
struct was generated by inserting the fragment covering 161–
330 amino acids of hGﬁ-1B cDNA to the EcoRI site of pVP16
vector. The retroviral vector for expressing Gﬁ-1B with
C-terminal FLAG-tag was constructed by ligating the coding
region of Gﬁ-1B-FLAG with the HpaI-digested pS2 plas-
mid. All constructs were veriﬁed by dideoxy termination
sequencing.
Retrovirus production and selection of stable cell line
S2 retroviral vectors expressing C-terminal FLAG-tagged
wild-type Gﬁ-1B was transfected to the packaging cell line
PT67. Stable clones were selected in the medium supplemen-
ted with G418 antibiotic (400 mg/ml). Following propagation
of each clone, viral supernatant from the individual culture
was collected and stored at  80 C. K562 cells were infected
with viral supernatant for 48 h. Subsequently, K562 cells were
kept in the medium containing G418 for further selection.
Stable clone was propagated and conﬁrmed by the detection
of FLAG-tagged Gﬁ-1B in the cell lysates by western blotting
using anti-FLAG antibodies (M2).
Transient-transfection and luciferase assays
We used electroporation for K562 cells transfection as
described previously (17). 293T cells plated on 35 mm dishes
were transiently transfected with a mixture containing 6 mgo f
lipofectamine (Invitrogen Life Technologies) and 1 mgo f
plasmid DNA. After transfection for 24 h, cells were washed
and lysed in a reporter lysis buffer (0.5 M HEPES, pH 7.8,
0.2% Triton X-100, 1 mM CaCl2 and 1 mM MgCl2), and 50 ml
of the cell lysates was mixed with 50 ml of luciferase assay
buffer (Packard). The luciferase activity was measured with a
luminescence counter (Packard).
Immunoprecipitation
Cells were seeded and transfected with a mixture of lipo-
fectamine (Invitrogen Life Technologies) and plasmid
DNA. After transfection for 24 h, cells were washed and
lysed in 50 mM Tris–HCl buffer (pH 7.5) containing 1%
Triton X-100, 150 mM NaCl, 0.1% SDS, 5 mM NaF and
proteinase inhibitors (Sigma). The lysates were centrifuged
at 10000 g for 5 min and pre-cleared by incubating with
normal mouse IgG and protein A beads for 30 min at 4 C. The
supernatants were immunoprecipitated using M2-Ab beads at
5332 Nucleic Acids Research, 2005, Vol. 33, No. 164 C for 4 h. The beads were then washed four times by the
lysis buffer and the proteins on the beads were separated by
10% SDS–PAGE.
Western blot analysis
Whole cell extracts (50 mg of protein) in RIPA buffer [50 mM
Tris–HCl, pH 7.6, 150 mM NaCl, 0.1% sodium deoxycholate
and SDS, 1% Triton X-100, 5 mM NaF, 5 mM Na4VO3 and
proteinase inhibitors (Sigma)] were separated on a 10% SDS–
polyacrylamide gel and transferred to a PVDF membrane
(Millipore). The anti-GATA-1 (C-20, Santa Cruz) was diluted
at 1:1000, anti-Gﬁ-1B (H-150, Santa Cruz), anti-b-tubulin
(Sigma) and anti-Myc (9E10, Santa Cruz) at 1:2000, and
anti-FLAG (M2, Sigma) at 1:5000, respectively. Enhanced
chemiluminescence detection of the horseradish peroxidase
reaction was performed according to the vendor’s instructions
(PerkinElmer Life Sciences).
RT–PCR assay
Total RNA was prepared for the synthesis of oligo(dT)-primed
cDNA usingthe superscript II(Invitrogen, Carlsbad, CA). One
micro liter of cDNA was then ampliﬁed using 30 cycles of
94 C for 30 s, 60 C for 45 s and 72 C for 1 min with speciﬁc
primers using Fast-Run  RT–PCR kit (Protech Technology
Enterprise). PCR products were separated on 10% polyacryl-
amide gel and visualized by ethidium bromide staining. The
primersequenceswereendogenousGﬁ-1Bsenseprimer50-GG-
AGAAGTATCTATTTGTGC-30, antisense primer 50-AGT-
CAAGCTTCAGCACAATGGGGCCCTC-30; Gﬁ-1B-FLAG
sense primer 50-CGGAATTCGCGTACCACTGTGTGAAG-
30, antisense primer 50-GTCGTCATCGTCTTTGTAGTC-
CAT-30; human hypoxanthine phosphoribosyltransferase
(HPRT) sense primer 50-AAGGACCCCACGAAGTGTTGG-
30, antisense primer 50-AGGGAACTGATAGTCTATAG-30;
human hTK1 sense primer 50-AGCTGCATTAACCTGCCC-
ACTC-30, antisense primer 50-GCACTTGTACTGAGCAA-
TATG-30.
RNA interference
The pS2-Gﬁ-1B-FLAG retrovirus integrated K562 cells
(3 · 10
6) were electroporated with or without the 100 nM
GATA-1 siRNA (custom SMART pool, hGATA-1,
NM_002049, Dharmacon Research Inc., Lafayette, CO).
Aftertransfection for24h,cells were harvested forthewestern
blot and chromatin immunoprecipitation.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed as described
previously (17). Antibodies used for immunoprecipitation
were anti-FLAG (Sigma) and anti-NF-YB (C-20, Santa
Cruz) antibodies. The immunoprecipitated DNA was applied
to PCR using the following thermal cycling program: 95 C for
5 min, 32 cycles of 30 s at 95 C, 30 s at 52 C and 45 s at 72 C,
followed by a 5 min extension time at 72 C. Thirty percent of
the products were separated by 10% PAGE and visualized
by ethidium bromide staining. The speciﬁc primers for the
hGﬁ-1B promoter were sense primer: 50-GAGTTTTA-
TAAGTTAGAGCT-30 and antisense primer: 50-AAATAGA-
TACTTCTCCTTTTTGC-30. The size of PCR product of
hGﬁ-1B promoter was 345 bp.
RESULTS
Gfi-1B transcription is down-regulated by ectopic
expression of Gfi-1B protein
To test the effect of Gﬁ-1B on its own promoter, a plasmid
expressing the C-terminus FLAG-tagged Gﬁ-1B under the
control of the cytomegalovirus promoter was co-transfected
with the human Gﬁ-1B promoter-luciferase construct into
K562 cells. As shown in Figure 1A, overexpression of Gﬁ-
1B-FLAG strongly reduced the Gﬁ-1B promoter activity to
30% of the control set, while a slight reduction of SV-40
promoter activity was seen under the same transfection con-
dition, indicating promoter-speciﬁc repression by Gﬁ-1B. To
know whether this auto-inhibition can occur under a condition
where Gﬁ-1B expression level is elevated moderately, we
constructed a retroviral expression vector of Gﬁ-1B-FLAG
under the control of LTR promoter. K562 cells were infected
by retrovirus generated from the empty and Gﬁ-1B-FLAG
retroviral vectors containing neomycin resistance gene. Fol-
lowed by clonal selection, G418 resistant clones were pooled
and subjected to RT–PCR and western blot analyses. Since
endogenous Gﬁ-1B RNA transcript contains a 50-untranslated
region (50-UTR) covering from exon1 to exon2 of the human
Gﬁ-1B gene (17), we ampliﬁed this 50-UTR sequence of endo-
genous Gﬁ-1B RNA from total cellular RNA by RT–PCR to
distinguish from Gﬁ-1B-FLAG transcript, which does not
have the 50-UTR sequence and was speciﬁcally ampliﬁed
by the FLAG primer for detection. In accordance with the
results from the reporter assay, cells stably expressing mod-
erateamountofGﬁ-1B-FLAGexhibitedamarkedreductionof
the expression level of endogenous Gﬁ-1B transcript as com-
pared with the cells selected from the control virus infection
(Figure 1B). Similarly, the western blot analysis also showed
that endogenous Gﬁ-1B protein was no longer detectable in
cells expressing Gﬁ-1B-FLAG (Figure 1C), conﬁrming that
the endogenous Gﬁ-1B gene in K562 cells is suppressed by
enforced expressed Gﬁ-1B-FLAG.
The contribution of Gfi-1-like sequences to the Gfi-1B
promoter activity
Since Gﬁ-1B is known as a transcriptional repressor with a
DNA-binding activity (1,9), we then examined whether the
human Gﬁ-1B promoter contains typical Gﬁ-1 binding site.
Sequence analysis of the Gﬁ-1B promoter has revealed two
potential tandem Gﬁ-1-like sites (AATC) at  59/ 56 and
 47/ 44 of the promoter region (Figure 2A). The in vivo
footprint analysis also clearly showed that this region was
well protected in genomic DNA of K562 cells as a contrast
to no protection in that of myeloid U937 cells (data not
shown). It is known that both Gﬁ-1 and Gﬁ-1B exhibit
DNA-binding activity to the same consensus sequence
(1,3). If this region were directly recognized by Gﬁ-1B, it
would be also protected in U937 cells which contain Gﬁ-1
but not Gﬁ-1B (22). We then tested whether these two tandem
AATC sequences play a role in negative regulation of Gﬁ-1B
promoter. The Gﬁ-1B promoter reporter plasmid containing
mutations of these two sites was constructed. The wild-type
and mutated-type reporters were transfected into K562 cells
for the promoter activity analysis (Figure 2B). Interestingly,
mutation of these two AATC sequences reduced the promoter
activity to 34% relative to the wild-type promoter, indicating
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negative, cis-elements in controlling the Gﬁ-1B promoter
activity in K562 cells. Overexpression of Gﬁ-1B signiﬁcantly
decreased the luciferase activity expressed from the wild-type
promoter, but not the AATC mutated-type reporter,
indicating that these two AATC sites still contribute to the
responsiveness to Gﬁ-1B-mediated repression. Accordingly,
we speculated that a positive regulator binding to these two
AATC sites may mediate repression effect of Gﬁ-1B on its
own promoter.
GATA-1 binds to the AATC sites
To examine whether the sequence containing two tandem
repeats of AATC can be recognized by Gﬁ-1B, we performed
the in vitro DNA gel-shift assay using radio-labeled DNA
fragment covering  70/ 41 region of the Gﬁ-1B promoter
sequence. Incubation of this probe with nuclear extract of
K562 cells gave rise to DNA–protein complexes I and II.
These two complexes were abolished by excess amounts of
the unlabeled oligomer (Figure 3A), but not by the oligomer
A
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Figure 1. Endogenous Gfi-1B transcription is repressed by ectopic expression of Gfi-1B in K562 cells. (A) K562 cells were transfected with the pGL2-SV40 or
pGL2-hG ( 145/+19) and pCMV-b-Gal together with control vector or Gfi-1B-FLAG expression vector as indicated. After transfection, each cell sample was
dividedintotwoparts.Oneforluciferaseactivityassay(leftpanel),andtheotherweresubjectedtowesternblotanalysis(rightpanel)usingantibodiesagainstGfi-1B
(H-150) or b-tubulin. The luciferase activity was normalized by b-galactosidase activity in each sample, and luciferase activity of the Gfi-1B promoter from cells
co-transfected with the control vector after normalization was set arbitrarily to 1. The data are means ± SD (n ¼ 3) from three independent experiments. (B) K562
cells infected by control (pS2) and Gfi-1B-FLAG expression retrovirus were G418 selected and harvested for RNA preparation. RT–PCR assay were performed
with 0.5 mg of each RNA sample and the specific primers for detecting endogenous Gfi-1B, TK1, HPRT and Gfi-1B-FLAG genes as described in Materials and
Methods. Bottom panel shows the RT–PCR results for detecting endogenous Gfi-1B RNA in reactions containing different amounts of total input RNA from
pS2 control cells. (C) Total lysates from the selected K562 cell lines as described above were subjected to western blot analysis using antibodies against Gfi-1B
(H-150), FLAG (M2) and b-tubulin.
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ﬁcity to the sequence containing AATC. One retarded com-
plex seen in the assay was indicated to be non-speciﬁc,
because various oligomers, including  70/ 41 of Gﬁ-1B pro-
moter,GATA,Gﬁ-1,AP2andSp1consensus sequences,could
also compete for its formation. Excess amount of unlabeled
Gﬁ-1 oligomer, which contains typical AATC core sequence,
was unable to compete for complex II formation, but with
some capacity of competing for complex I. However, complex
I formation was unaffected by pre-incubation of K562 extract
with speciﬁc Gﬁ-1B antibody. Interestingly, complex II
formation could be supershifted by the speciﬁc GATA-1 anti-
body and competed by excess amount of unlabeled consensus
GATA oligomer, while the mutated GATA oligomer with a
deviation of GATA to CTTA was unable to compete for com-
plex II formation. Unlike the denoted non-speciﬁc complex,
complex II formation was unaffected by either AP2, Sp1 or
Gﬁ-1 oligomers. Altogether, these results strongly suggest that
GATA-1 binds to the tandem AATC sites within the  70/ 41
region. Since complex I could not be competed by the GATA
consensus oligomer, binding of GATA-1 is unlikely to be
involved in this complex formation. Although there is a
third AATC site located on the reverse strand within the
 70/ 41 region, we found that GATA-1 was unable to
bind to the AATC mutated probe, which retains the intact
third AATC sequence on the reverse strand (data not
shown). Nor did mutation of this third AATC site decrease
the Gﬁ-1B promoter activity expressed in K562 cells (data not
shown). Here, we excluded the possibility that GATA-1 can
bind to the Gﬁ-1B promoter via the third AATC on the reverse
strand.
Since 293T cells do not express Gﬁ-1B and GATA-1, we
then ectopically expressed GATA-1 or Gﬁ-1B-FLAG in this
cell line for nuclear extract preparation and gel-shift assays.
Radio-labeled  70/ 41 probe formed speciﬁc complexes I
and II with nuclear extracts of cells expressing GATA-1.
These two complexes were abolished by excess amount
of unlabeled GATA consensus oligonucleotide but not by
Gﬁ-1 oligomer (Figure 3B). In contrast, nuclear extract of
cells expressing Gﬁ-1B was unable to form any speciﬁc
7complex with the  70/ 41 probe (Figure 3C). One complex
formed in these gel-shift assays shown in Figure 3B and C was
denoted non-speciﬁc, since this complex could be competed
by various unrelated oligomers when using 293T cell extracts
expressing either Gﬁ-1B-FLAG or GATA-1 for the assays. To
test whether Gﬁ-1B protein in this nuclear extract is functional
in binding to the consensus Gﬁ-1 oligonucleotide, we then
prepared the radio-labeled Gﬁ-1 consensus oligomer for the
gel-shift assay. As shown in Figure 3D, nuclear extracts of
cells expressing Gﬁ-1B-FLAG did form speciﬁc complex with
consensus Gﬁ-1 oligomer probe, which could be super-shifted
by the speciﬁc Gﬁ-1B or FLAG antibody and abolished by
excessive amount of unlabeled consensus oligomer. There-
fore, lack of complex formation between the Gﬁ-1B promoter
probe with extracts containing Gﬁ-1B protein is not due to that
the Gﬁ-1B-FLAG protein expressed in 293T cells is defective
in speciﬁc DNA binding. Figure 3E showed the ectopic
expression of Myc-GATA-1 and Gﬁ-1B-FLAG in nuclear
extracts of 293T cells. These gel-shift data led us to conclude
that GATA-1, instead of Gﬁ-1B, binds to the AATC sites
within the  70/ 41 region of the human Gﬁ-1B promoter.
Both non-typical and typical GATA sites contribute to
GATA-1-mediated transcriptional activation of
Gfi-1B gene
Our previous study has shown that in K562 cells GATA-1
binds to the typical GATA-site located at  132/ 129 of
the Gﬁ-1B promoter to mediate transcriptional activation
(17). Here, we further compared the contribution of the typical
GATA (G1) site at  132/ 129 and non-typical GATA sites
(two AATC at  59/ 56 and  47/ 44 positions) in GATA-1-
mediated transcription of the Gﬁ-1B promoter. Co-transfection
with GATA-1 expression vector for the reporter assay indic-
ated that either mutation of GATA site at the G1 or two AATC
sites reduced the GATA-1-activating effect signiﬁcantly
(Figure 4). Thus, both GATA and AATC sites are recognized
by GATA-1 for transcriptional activation.
Gfi-1B inhibits GATA-1-mediated transcription
Given that GATA-1 is essential for activating the Gﬁ-1B pro-
moter, we then raised the question whether GATA-1-mediated
transcription is inhibited by co-expression of Gﬁ-1B protein.
To address this question, we transfected 293T cells with
A
B
Figure 2. The Gfi-1-like sequences in the human Gfi-1B promoter act as a
positive cis-element in transcription. (A) Schematic representation of the Gfi-
1-like sites in the Gfi-1B promoter. (B) K562 cells were co-transfected with
wild-type or AATC mt ( 70/ 41 mutation) of pGL2-hG ( 325/+19) reporter
constructtogetherwithpCMV-b-Galincombinationwitheithercontrolvector
or Gfi-1B-FLAG expression vector as indicated. The luciferase activities after
normalization by b-galactosidase were calculated relative to that in the
cells transfected with wild type of pGL2-hG ( 325/+19) and control vector,
which was set arbitrarily to 1. The data are means ± SD (n ¼ 3) from three
independent experiments.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5335AB
CD E
Figure 3. GATA-1canbindtoAATCsequencesintheGfi-1Bpromoter.(A)Gel-shiftassaysofthe 70/ 41regionofthehumanGfi-1Bpromoter.The
32P-labeled
double-stranded oligonucleotide containing  70/ 41 sequence of the Gfi-1B promoter was used for the assays in the absence or presence of unlabeled competitor
(80·) with 10 mg of nuclear protein extracted from K562 cells as indicated. The sequence of each competitor is shown below. Control IgG, Gfi-1B (H-150)
andGATA-1(C-20)antibodieswereaddedtothereactionmixtureswhereindicated.(B)Gel-shiftassaysofthe 70/ 41regionofthehumanGfi-1Bpromoterusing
2.5 mg of nuclear extracts from 293T cells overexpressing Myc-GATA-1. For the competition experiments, various unlabeled competitor as indicated in 80-fold
molar excess was included in the reaction mixture. GATA-1 (C-20) antibody was added to the reaction mixtures. (C) Gel-shift assays of the  70/ 41 region of the
human Gfi-1B promoter using 2.5 mg of nuclear extracts from 293T cell overexpressing Gfi-1B-FLAG. For the competition experiments, various unlabeled
competitorin80-foldmolarexcesswasincludedinthereactionmixture.GATA-1(C-20)orFLAG(M2)antibodywasaddedtothereactionmixtureswhereindicated.
(D) Consensus Gfi-1 DNA-binding oligomer was
32P-labeled for gel-shift assay using 2.5 mg of nuclear extracts from 293T cell overexpressing Gfi-1B-FLAG
protein. Each assay contained 2.5 mg of nuclear protein extracted from 293T cells expressing Gfi-1B-FLAG protein. For the competition experiments, unlabeled
competitorin80-foldmolarexcesswasincludedinthereactionmixture.Gfi-1B(H-150)orFLAG(M2)antibodywasaddedtothereactionmixtureswhereindicated.
(E)293Tcellsweretransfectedthecontrolvector,pMyc-GATA-1andGfi-1B-FLAGexpressionvectorasindicated.Aftertransfection,30mgoftotallysateprotein
was subjected to SDS–PAGE and western blot analysis using antibodies against Myc (9E10), Gfi-1B-FLAG (M2), and b-tubulin.
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with expression vector of GATA-1 in the presence or absence
of Gﬁ-1B-FLAG co-expression (Figure 5A). It turned out that
co-expression of Gﬁ-1B speciﬁcally repressed GATA-1-
dependent activation of luciferase activity derived from
3XGATA-reporter. Similar results were also seen in the
cells that were transfected with Gﬁ-1B promoter luciferase
construct (Figure 5B). Clearly, Gﬁ-1B negatively auto-
regulates its own promoter through repressing GATA-1-
mediated transcription. Since Gﬁ-1B is unable to bind to
GATA sequence, these data also suggest that Gﬁ-1B-
mediated repression need not work through its binding to
the recognition sequence.
Gfi-1B interacts with GATA-1
To assess the mechanism responsible for the repression of
GATA-1-mediated transcription by Gﬁ-1B, we then tested
whether Gﬁ-1B interacts with GATA-1 by transfecting
293T cells with expression vectors of Gﬁ-1B-FLAG and
Myc-GATA-1 for the co-immunoprecipitation experiment. As
shown in Figure 6A, Myc-GATA-1 was co-immunopre-
cipiated with Gﬁ-1B-FLAG by anti-FLAG M2 antibody in
the cell lysate co-expressing Gﬁ-1B-FLAG and Myc-
GATA-1, while no myc-GATA-1 was precipitated in the
cell lysate expressing Myc-GATA-1 alone. This result sug-
gests that co-expression of both proteins can form a speciﬁc
complex in the cells. We then further deﬁned the domain
necessary for their interaction. GATA-1 contains two zinc
ﬁngers. One is the carboxyl ﬁnger spanning 257–287 amino
acids which is essential for DNA binding and the other
N-terminal ﬁnger at 199–255 amino acids which stabilizes
its binding to the GATA sequence (23–25). We then construc-
ted different deleted forms of pMyc-GATA-1 for the co-
immunoprecipitation experiment. After co-expression with
Gﬁ-1B-FLAG in 293T cells, we found that both the wild-
type and 1–287, but not 1–199 or 1–255, forms of Myc-
GATA-1, formed a complex with Gﬁ-1B-FLAG (Figure 6B),
indicating that carboxyl ﬁnger of GATA-1 is necessary for its
interaction with Gﬁ-1B protein.
Gﬁ-1B contains a SNAG domain in the N-terminus medi-
ating its transcriptional repression and six zinc-ﬁnger domains
at its C-terminus for DNA binding (1–3). To examine
the domain of Gﬁ-1B that is involved in complex formation
with GATA-1 protein, we expressed various deleted forms
of FLAG-Gﬁ-1B with Myc-GATA-1 in 293T cells for
co-immunoprecipitation experiment. As shown in Figure 6C,
deletion of carboxyl zinc-ﬁnger (C-del) abrogated the inter-
action of FLAG-Gﬁ-1B with myc-GATA-1, indicating the
requirement of the carboxyl zinc-ﬁnger of Gﬁ-1B for its
interaction with GATA-1.
The SNAG domain of Gfi-1B is required for inhibiting
GATA-1-mediated trans-activation
To know whether overexpression of Gﬁ-1B affects the DNA-
binding activity of GATA-1, we performed the gel-shift assay
using consensus GATA binding oligonucleotides as the probe
Figure 4. Both non-typical and typical GATA-1 sites contribute to GATA-1-
mediatedtranscriptionalactivationofGfi-1Bgenes.ThepGL2-hG( 325/+19)
constructs of wild type, G1 mt ( 132/ 129 mutation) or AATC mt ( 70/ 41
mutation) were each co-transfected with the GATA-1 expression vector in
K562 cells, and luciferase activities were determined. The luciferase activities
werestandardizedrelativetob-galactosidaseexpressionandexpressedrelative
to wild type of pGL2-hG ( 325/+19) that was set arbitrarily to 1. The data are
means ± SD from three independent experiments.
A
B
Figure 5. Gfi-1B inhibits GATA-1-mediated trans-activation in 293T cells.
(A) 293T cells were transfected with a reporter plasmid containing 3XGATA-
specificbindingsequencesorabasalthymidinekinasepromoter(pT81-Luc)in
the presence of the control, GATA-1, Gfi-1B or GATA-1 plus Gfi-1B expres-
sion vector as indicated. The luciferase activities after normalization by were
calculatedrelativetothatinthecellsco-transfectedwiththecontrolvector.The
data represent averages from three independent experiments. (B) 293T cells
were transfected with the pGL2-hG ( 325/+19) and pCMV-b-Gal together
with control vectors, GATA-1, Gfi-1B alone or GATA-1 and Gfi-1B expres-
sion vector as indicated. The luciferase activities after normalization by
b-galactosidase were calculated relative to that in the cells transfected with
wildtypeofpGL2-hG( 325/+19)andcontrolvector,whichwassetarbitrarily
to 1. The data represent averages from three independent experiments.
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of increasing amounts of Gﬁ-1B-FLAG in nuclear extract did
not perturb the speciﬁc GATA-1/DNA complex formation in
the binding reaction (data not shown), indicating that Gﬁ-1B
does not interfere with DNA-binding activity of GATA-1. We
then turned to determine whether the repression domain of
Gﬁ-1B is responsible for suppressing GATA-1-mediated
trans-activation. Toward this end, Gﬁ-1B promoter luciferase
construct was co-transfected with various deleted forms of
FLAG-Gﬁ-1B constructs and GATA-1 expression vector
into 293T cells. As shown in Figure 7A, removal of SNAG
repression domain relieved the repressive effect of Gﬁ-1B on
GATA-1-mediated transcription, suggesting the SNAG
domain is required for suppressing GATA-1-mediated tran-
scription of the Gﬁ-1B promoter. Because the C-del Gﬁ-1B
loses the ability to interact with GATA-1, as expected, its
expression did not affect GATA-1-mediated trans-activation.
Furthermore, replacement of SNAG domain by a herpes virus
trans-activating protein, VP16, converted Gﬁ-1B to an activ-
ator for GATA-1-mediated transcriptional activation of Gﬁ-1B
promoter. Thus, the interaction between GATA-1 and Gﬁ-1B
does not affect the DNA-binding activity of GATA-1, and the
SNAG domain of Gﬁ-1B contributes to its repression function
onGATA-1-mediated transcription.To ascertain thatthe func-
tional effect of Gﬁ-1B on its own promoter is indeed through
GATA-1bindingtotheAATCsites, we comparedthe effectof
VP16-Gﬁ-1B on GATA-1-mediated activation of wild-type
and AATC-mut Gﬁ-1B promoter reporter. As shown in
Figure 7B, stimulation of GATA-1-mediated activation of
Gﬁ-1B promoter by VP16-Gﬁ-1B was diminished by disrupt-
ing the AATC sites. In summary, Gﬁ-1B can speciﬁcally
interact with GATA-1, by which GATA-1-dependent
A
BC
Figure 6. Gfi-1B interacts with GATA-1. (A) Expression vector of Myc-GATA-1 together with either the control (C) or Gfi-1B-FLAG expression vector was
transfected into 293T cells. After transfection for 24 h, whole cell lysates were prepared and immunoprecipitated with anti-FLAG (M2) beads or control IgG. The
immunoprecipitates were subjected to immunoblot analysis with anti-Myc antibody. The blot was reprobed with anti-FLAG (M2) antibody to confirm that Gfi-1B
was successfullyimmunoprecipitated.The inputindicated 10% ofthe whole cell lysate usedforthe co-immunoprecipitation.(B) Schematic representationof wild-
type and deletion constructs of GATA-1 (upper panel). N-ZF indicates N-terminal zinc finger; C-ZF, C-terminal zinc-finger. Various deleted constructs of Myc-
GATA-1 were co-transfected with Gfi-1B-FLAG into 293T cells. Cells were harvested for immunoprecipitation, and the immunoprecipitates were subjected to
immunoblotanalysiswithanti-Myc(9E10)andanti-FLAG(M2)antibodyasdescribedabove.(C)SchematicrepresentationofdeletionconstructsofGfi-1B(upper
panel).Controlvector,wildtype,N-del(164–330)orC-del(1–137)deletionconstructofFLAG-Gfi-1BwascostransfectedwithMyc-GATA-1into293Tcells.Cells
were harvested for immunoprecipitation and the immunoprecipitates were subjected to immunoblot analysis with anti-Myc (9E10) and anti-FLAG (M2) antibody.
5338 Nucleic Acids Research, 2005, Vol. 33, No. 16transcriptioncanbesuppressedbyGﬁ-1B-mediatedrepression
via its SNAG domain.
GATA-1-dependent binding of Gfi-1B to its own
promoter
Finally, we tested whether GATA-1 is required for Gﬁ-1B-
FLAG binding to the Gﬁ-1B promoter in K562 cells. Toward
this end, we depleted the expression of GATA-1 in K562 cells
stably expressing Gﬁ-1B-FLAG by transfecting these cells
with siRNA of GATA-1 (Figure 8A). We then performed
the chromatin immunoprecipitation experiments in Gﬁ-1B-
FLAG expressing cells with FLAG antibody to determine
the effect of GATA-1 depletion on Gﬁ-1B-FLAG binding to
the Gﬁ-1B promoter region. As shown in Figure 8B, FLAG
antibody was able to immunoprecipitate formaldehyde-ﬁxed
chromatin containing endogenous Gﬁ-1B promoter DNA
from cells without GATA-1 depletion. For cells depleted of
GATA-1, FLAG antibody no longer immunoprecipitated
endogenous Gﬁ-1B promoter DNA, indicating the necessary
role of GATA-1 in mediating Gﬁ-1B association with its own
promoter in vivo. Our previous study has shown that NF-Y
binds to the Gﬁ-1B promoter for transcriptional activation.
Here, we showed that GATA-1 depletion did not signiﬁcantly
alter NF-Y binding with the endogenous Gﬁ-1B promoter
region, indicating the speciﬁc effect of GATA-1 on Gﬁ-1B-
FLAG binding to the human Gﬁ-1B promoter. These ChIP
results further supported the role of GATA-1 as a mediator in
Gﬁ-1B auto-regulation.
DISCUSSION
It is well known that the auto-regulatory loop provides a
mechanism by which the concentration of the transcriptional
regulator is highly controlled. Gﬁ-1B is a transcriptional
repressor, whose function has been shown to directly repress
transcription of Socs1 and Socs3 in hematopoietic cells (9).
Recent studies using retroviral vector-mediated expression of
Gﬁ-1B further showed that elevated expression of Gﬁ-1B
alters behavior of proliferation and differentiation of erythroid
A
B
Figure 7. The SNAG domain of Gfi-1B is required for repressing GATA-1-
mediated trans-activation. (A) 293T cells were transfected with pGL2-hG
( 325/+19)togetherwithwithpCMV-b-Galincombinationwitheithercontrol
vector, GATA-1 alone or GATA-1 plus wild-type, DSNAG (45–330) or C-del
(1–137) truncated FLAG-Gfi-1B expression vector as indicated. All the luci-
ferase activities were calculated and expressed as described in the legend to
Figure 5B. The data represent averages from three independent experiments.
(B) 293T cells were transfected with the wild-type or AATC mt of pGL2-hG
( 325/+19) constructs together with the expression vector of GATA-1 and
pCMV-b-Gal in the presence of control vector or VP16-Gfi-1B plasmid.
Luciferase activities were determined and expressed as described in the legend
to Figure 5B. The data are means ± SD from three independent experiments.
A B
Figure 8. GATA-1 is required for Gfi-1B-FLAG occupancy at the Gfi-1B promoter. (A) The pS2-Gfi-1B-FLAG retrovirus integrated K562 cells (3 · 10
6) were
electroporatedwithorwithoutGATA-1siRNA.TotalcelllysatesfromtheelectroporatedK562cellsweresubjectedtowesternblotanalysisusingantibodiesagainst
GATA-1 (C-20), Gfi-1B (H-150) and b-tubulin. (B) ChIP assays were performed with equal amount of the electroporated pS2-Gfi-1B-FLAG cells (3 · 10
6)a s
described in Materials and Methods. Samples of sonicated and purified chromatin were immunoprecipitated with anti-FLAG M2 beads or anti-NF-YB (C-20)
antibodyasindicated,andDNAisolatedfromimmunoprecipitatedmaterialwasamplifiedbyPCRwithprimersspecificfortheGfi-1Bpromoter.Differentamounts
of chromatin samples prior to immunoprecipitation were also amplified to indicate the linearity of PCR for the Gfi-1B promoter and relative amount of total input
chromatin.
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its expression level needs to be regulated within the erythroid
differentiationprogram.Inthiswork,ourdatasuggestthatGﬁ-
1B is auto-regulated in a negative manner. However, unlike
otherauto-regulatoryloop,hereweshow thattheexpressionof
Gﬁ-1B regulates its own promoter through its interaction with
GATA-1. These results also suggest a new mode of Gﬁ-1B
action, in which Gﬁ-1B negatively modulates GATA-1-
mediated transcription through protein interaction without
direct binding to its recognition sequence.
OurpreviousstudyhasshownthatGATA-1bindstotheGﬁ-
1B promoter at  132/ 129 GATA site (17) and plays a neces-
sary role in trans-activating the Gﬁ-1B promoter in K562 cells.
However, GATA mutation at the  132/ 129 site did not
abolish GATA-1-mediated activation of the Gﬁ-1B transcrip-
tion, indicating that additional GATA-1 recognition site is
present in the promoter. Using nuclear extracts from cells
overexpressing GATA-1, our gel-shift data revealed that
GATA-1 also binds to the region containing two tandem
AATC (GATT in the reverse strand) sites at  59/ 56 and
 47/ 44. Moreover, GATA-1-mediated activation of Gﬁ-1B
promoterwas diminished by mutationsintroducedtothesetwo
AATC sites, suggesting GATA-1 works on these two non-
typical GATA sites for trans-activation.
The gene targeting experiments have demonstrated that
both GATA-1 and Gﬁ-1B genes are essential for erythropoiesis
(5,10,11,26–28). The expression patterns of these two genes
have been shown to be well correlated throughout successive
differentiation stages from erythroid-blast-forming units to
mature erythroblasts (5). Data from our studies using the pro-
moter analysis indicate that GATA-1 works on GATA and
AATC sites to activate Gﬁ-1B transcription, which accounts
for their co-expression pattern. Interestingly, here we show
that the mechanism of GATA-1-mediated transcriptional
activation of Gﬁ-1B expression is intriguingly restricted by
negative auto-regulation of Gﬁ-1B through their interaction,
by which GATA-1-mediated transcription is repressed via the
SNAG domain of Gﬁ-1B. Conceivably, this auto-regulatory
mechanism provides a means to limit the expression level of
Gﬁ-1B in erythroid cells. Since GATA-1 is a central regulator
in terminal differentiation of erythroid cells (27,29,30), this
auto-regulatory loop is particularly important in controlling
the amount of Gﬁ-1B expression in a range that would
not perturb the transcription function of GATA-1 during
erythropoiesis.
Up to now, LMO-2 (31,32), FOG-1 (33), Pu.1 (34–36), CBP
(37), Fli-1 (38), Ski (39), EKLF/Sp1 (40) and Herp2 (41) have
been shown to interact with GATA-1. Among them, Pu.1 and
Ski repress GATA-1-mediated trans-activation by inhibiting
its DNA-binding activity through their physical interaction
(36,39). Unlike these two negative regulators but similar to
Herp2 (41), Gﬁ-1B did not affect DNA-binding activity of
GATA-1. Rather, the inhibitory effect is dependent on its
SNAG repression domain, since replacement of SNAG
domain by VP16 converts Gﬁ-1B from a co-repressor to a
co-activator in GATA-1-dependent transcription. Our ﬁnding
adds Gﬁ-1B to the list of transcriptional regulators that interact
with GATA-1. It should be mentioned that we did not ﬁnd the
direct interaction between these two proteins when yeast two-
hybrid system was used for the interaction assay (data not
shown). Therefore, it is possible that Gﬁ-1B and GATA-1
may require the involvement of other cellular factor or certain
post-translational modiﬁcation for their complex formation. If
this is true, it would suggest that the inhibitory effect of Gﬁ-1B
on GATA-1 is modulated in a cell context-dependent manner.
Alternatively, it is also possible that the effect of Gﬁ-1B on
GATA-1 function depends on other interacting factors and the
gene promoter context as well. More experiments are needed
to deﬁne the factors involved in their functional interaction for
further understanding how the interplay between GATA-1 and
Gﬁ-1B is regulated during terminal maturation and survival of
erythroid cells.
While this manuscript was in its revision preparation,
Rodriguez et al. (19) reported that Gﬁ-1B is present in the
pull-down complexes containing GATA-1 protein in MEL
cells and that Gﬁ-1B and GATA-1 are bound to the myc
and myb promoters in vivo. Accordingly, they proposed that
GATA-1 forms a repressive complex with Gﬁ-1B to repress
expression of myc and myb, thus prohibiting proliferation of
erythroid cells that express elevated level of Gﬁ-1B. While
their hypothesis remains to be elucidated, data from our ChIP
and reporter analyses demonstrated that Gﬁ-1B represses and
binds to its own promoter in vivo dependent on the presence of
GATA-1, providing the ﬁrst direct evidence of Gﬁ-1B/GATA-
1 repression mechanism. Apparently, the Gﬁ-1B promoter is
onetypical target gene forGATA-1/Gﬁ-1B complex-mediated
repression in erythroid cells. Taken together, we propose that
the expression of Gﬁ-1B and the function of GATA-1 in ery-
throid lineage cells are mutually regulated to ﬁnely tune their
functions.
Although AATC is the core sequence of a consensus Gﬁ-1
binding site (1,3), data from different approaches in this study
suggest that Gﬁ-1B cannot bind to this DNA region of its own
promoter. First, we found that the DNA–protein complexes
formed in the gel-shift assay using  70/ 41 probe with nuc-
lear extracts of K562 cells could not be competed by Gﬁ-1
binding consensus oligomer. Although this probe could also
form another prominent complex with K562 extract, we found
that all unrelated oligomers tested in this study competed for
this complex formation, indicating the non-speciﬁc nature
of this complex in our gel-shift assay (Figure 3A). Second,
Gﬁ-1B expressed in 293T cells did not form any speciﬁc
complex when Gﬁ-1B promoter sequence was used as the
probe for the gel-shift assay, while the same extract could
form speciﬁc complex with the Gﬁ-1 consensus oligomer
probe. All our results suggest that these two AATC sites
are preferentially recognized by GATA-1 in K562 cells for
transcriptional activation of Gﬁ-1B gene.
Contradictory to the results shown here, the report by
Vassen et al. (18) has described that in vitro translated Gﬁ-
1B formed speciﬁc complexes with the mouse Gﬁ-1B pro-
moter sequence probe covering the two AATC sites in the
gel-shift assays. Their results suggest that Gﬁ-1B can repress
its own promoter by recognizing these AATC sites directly.
The discrepancy in Gﬁ-1B binding to these AATC sites in
these two studies could be due to the difference in preparation
of Gﬁ-1B protein for the gel-shift assays. In the present study,
we used Gﬁ-1B expressed in nuclear extract for the binding
assay, while in vitro translated Gﬁ-1B in reticulocyte lysate
was used in their assay condition. Perhaps, co-factor present
in reticulocyte lysate can assist or promote the binding of Gﬁ-
1B to this sequence. It is worth of noting that in their report,
5340 Nucleic Acids Research, 2005, Vol. 33, No. 16inclusion of excess amount of unlabeled Gﬁ-1B promoter
sequence did not abolish the DNA/protein complex formation
between the consensus Gﬁ-1 oligomer and in vitro translated
Gﬁ-1B, indicating a higher binding afﬁnity of Gﬁ-1B to
the consensus Gﬁ-1 oligomer than to the Gﬁ-1B promoter
sequence. Their study has shown that enforced expression
of Gﬁ-1B under the control of the vav promoter in transgenic
mice inhibits endogenous Gﬁ-1B transcription in spleen but
not in bone marrow, suggesting that negative auto-regulation
of Gﬁ-1B is highly dependent on the cellular context.
According to our data in K562 cell, the preferential binding
of GATA-1 to the AATC sites and the interaction capability
between GATA-1 and Gﬁ-1B make a cellular context for the
negative auto-regulation of Gﬁ-1B through GATA-1. Never-
theless, here we do not exclude the possibility that Gﬁ-1B
when expressed in abundant amount may still be able to recog-
nize the Gﬁ-1B promoter through direct binding to the AATC
sites in NIH3T3 cells that are deﬁcient in GATA-1 expression.
Our ﬁndings in K562 cells may represent a situation that an
increase of Gﬁ-1B expression leads to a repression complex
formation through interacting with GATA-1 that has occupied
at the promoter. Thus, GATA-1 acts as an activator or a
repression mediator by sensing the amount of Gﬁ-1B present
in K562 cells.
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